Wei Jiang - 12 Nov 2025 Form 4 Insider Report for STAAR SURGICAL CO (STAA)

Role
Director
Signature
/s/ Nathaniel Sisitsky as attorney-in-fact for Wei Jiang
Issuer symbol
STAA
Transactions as of
12 Nov 2025
Transactions value $
$0
Form type
4
Filing time
14 Nov 2025, 18:00:23 UTC
Previous filing
02 Oct 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Jiang Wei Director 25510 COMMERCENTRE DRIVE, LAKE FOREST /s/ Nathaniel Sisitsky as attorney-in-fact for Wei Jiang 14 Nov 2025 0001867980

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STAA Common Stock Options Exercise $0 +21K +85.54% $0.00 45.5K 12 Nov 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STAA Restricted Stock Units Options Exercise $0 -21K -50% $0.00 21K 12 Nov 2025 Common Stock 21K $0.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects restricted stock units (RSUs) granted to the Reporting Person on May 12, 2025. These RSUs vested as to 1/3 of the shares subject to the award (20,967 shares) on August 12, 2025 and 1/3 (20,967 shares) on November 12, 2025, and will vest as 1/3 (20,967 shares) on January 12, 2026.
F2 Each RSU represents the right to receive one share of the Corporation's common stock upon vesting.

Remarks:

As disclosed in the Corporation's Current Report on Form 8-K filed on April 24, 2025, the Corporation entered into a consulting agreement with Mr. Jiang to serve as a special strategic advisor to the Corporation's Asia Pacific business through the end of fiscal 2025, in the temporary role of Chief of APAC Strategy. This Form 4 reflects the vesting of RSUs granted to Mr. Jiang in connection with such service.